VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement - The Manila Times
Voyager Acquisition→VERAXA Biotech
May 28, 2026
Kaos Capital has acquired BioRestorative Therapies, a healthcare services other business in Miami, for an undisclosed amount. Kaos Capital acquisitions include a 4.9% stake purchase in BioRestorative Therapies (NASDAQ: BRTX) through open-market stock purchases. BioRestorative Therapies operates in healthcare services other, and Kaos Capital seeks a strategic review and potential pivot toward AI opportunities to unlock shareholder value. The healthcare M&A is an add on acquisition led by a Miami-based hedge fund activist investor, with Kaos Capital planning to request an immediate meeting with the BRTX board to discuss strategy, operations, corporate governance, and value-creation pathways.
Voyager Acquisition→VERAXA Biotech
May 28, 2026
VERAXA Biotech
May 28, 2026
Carriage Services→McCammon Ammons Click Funeral Home
May 27, 2026
DePuy Synthes→MinMaxMedical
May 27, 2026
Olympus→BioProtect
May 27, 2026